Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures

Neurobiology of Aging

Volumn 28, Issue 5, 2007, Pages 727-734

  Mueller, Jakob C ^a   Riemenschneider, Matthias ^a   Schoepfer Wendels, Andreas ^a   Gohlke, Henning ^a,b   Konta, Lidija ^a   Friedrich, Patricia ^a   Illig, Thomas ^b   Laws, Simon M ^a   Förstl, Hans ^a   Kurz, Alexander ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Alzheimer's disease; Genetic association study; Haplotype; IDE; LD; Mini mental state examination; SNP

Indexed keywords

INSULINASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALLELES; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COGNITION; FEMALE; HAPLOTYPES; HUMANS; INSULYSIN; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 33847379373     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.03.009     Document Type: Article

References (44)

1. Abraham R., Myers A., Wavrant-DeVrieze F., Hamshere M.L., Thomas H.V., Marshall H., et al. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 109 6 (2001) 646-652
2. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
3. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290 (2000) 2302-2303
4. Bian L., Yang J.D., Guo T.W., Sun Y., Duan S.W., Chen W.Y., et al. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology 63 2 (2004) 241-245
5. Bickeboller H., Campion D., Brice A., Amouvel P., Hannequin D., Didierjean O., et al. Alzheimer's disease: genotype specific risks by age and sex. Am J Hum Genet 60 (1997) 439-446
6. Blacker D., Bertram L., Saunders A., Moscarillo T., Albert M., Wiener H., et al. Results of a high resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12 (2003) 23-32
7. Blomqvist M.E., Chalmers K., Andreasen N., Bogdanovic N., Wilcock G.K., Cairns N.J., et al. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging 26 6 (2005) 795-802
8. Blomqvist M.E., Silburn P.A., Buchanan D.D., Andreasen N., Blennow K., Pedersen N.L., et al. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics 5 2 (2004) 115-119
9. Boussaha M., Hannequin D., Verpillat P., Brice A., Frebourg T., and Campion D. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 329 1 (2002) 121-123
10. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
11. Daw E., Payami H., Nemens E., Nochlin D., Bird T., Schellenberg G., et al. The number of trait loci in late-onset Alzheimer's disease. Am J Hum Genet 66 (2000) 196-204
12. Edbauer D., Willem M., Lammich S., Steiner H., and Haass C. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277 16 (2002) 13389-13393
13. Edland S.D., Wavrant-De Vriese F., Compton D., Smith G.E., Ivnik R., Boeve B.F., et al. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett 345 1 (2003) 21-24
14. Ertekin-Taner N., Allen M., Fadale D., Scanlin L., Younkin L., Petersen R.C., et al. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat 23 4 (2004) 334-342
15. Ertekin-Taner N., Graff-Radford N., Younkin L., Eckerman C., Baker M., Adamson J., et al. Linkage of plasma Ab42 to a quantitative locus on chromosome 10 in late onset Alzheimer's disease pedigrees. Science 290 (2000) 2303-2304
16. Ertekin-Taner N., Ronald J., Feuk L., Prince J., Tucker M., Younkin L., et al. Elevated amyloid β protein (Aβ42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet 14 3 (2005) 447-460
17. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta-analysis. JAMA 278 (1997) 1349-1356
18. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100 7 (2003) 4162-4167
19. Farris W., Mansourian S., Leissring M.A., Eckman E.A., Bertram L., Eckman C.B., et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164 4 (2004) 1425-1434
20. Folstein M.F., Folstein S.E., and McHugh P.R. 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12 (1975) 189-198
21. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356
22. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 3 (2001) 306-309
23. Kehoe P., Vrieze F.W.-D., Crook R., Wu W., Holmans P., Fenton I., et al. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8 (1999) 237-245
24. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 6 (2003) 1087-1093
25. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 2 (2003) 177-182
26. McKhann G., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
27. Miller B.C., Eckman E.A., Sambamurti K., Dobbs N., Chow K.M., Eckman C.B., et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100 10 (2003) 6221-6226
28. Mueller J.C., Lohmussaar E., Magi R., Remm M., Bettecken T., Lichtner P., et al. Linkage disequilibrium patterns and tagSNP transferability among European populations. Am J Hum Genet 76 3 (2005) 387-398
29. Mukherjee A., Song E., Kihiko-Ehmann M., Goodman Jr. J.P., Pyrek J.S., Estus S., et al. Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci 20 23 (2000) 8745-8749
30. Myers A., De-Vrieze F.W., Holmans P., Hamshere M., Crook R., Compton D., et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 114 (2002) 235-244
31. Myers A., Holmans P., Marshall H., Kwon J., Meyer D., Ramic D., et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290 (2000) 2304-2305
32. Neale B.M., and Sham P.C. The future of association studies: gene-based analysis and replication. Am J Hum Genet 75 3 (2004) 353-362
33. Nowotny P., Hinrichs A.L., Smemo S., Kauwe J.S., Maxwell T., Holmans P., et al. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiat Genet (2005)
34. Pericak-Vance M., Bass M., Yamaoka L., Gaskell P., Scott W., Terwedow H., et al. Complete genomic screen in late onset Alzheimer's disease. JAMA 278 (1997) 1237-1241
35. Prince J.A., Feuk L., Gu H.F., Johansson B., Gatz M., Blennow K., et al. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 22 5 (2003) 363-371
36. Qin Z.S., Niu T., and Liu J.S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 71 5 (2002) 1242-1247
37. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273 49 (1998) 32730-32738
38. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., et al. CAMDEX. A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiat 149 (1986) 698-709
39. Sakai A., Ujike H., Nakata K., Takehisa Y., Imamura T., Uchida N., et al. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population. Am J Med Genet B Neuropsychiat Genet 125 1 (2004) 87-91
40. Saunders A.M., Schmader K., Breitner J.C.S., Benson M.D., Brown W.T., Goldfarb L., et al. Apolipoprotin E e4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342 (1993) 710-711
41. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20 5 (2000) 1657-1665
42. Welsh K.A., Butters N., Mohs R.C., Beekly D., Edland S., Fillenbaum G., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 44 (1994) 609-614
43. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., and Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53 2 (2002) 79-91
44. Zivelin A., Rosenberg N., Peretz H., Amit Y., Kornbrot N., and Seligsohn U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43 (1997) 1657-1659